Skip to main content
Log in

Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells

  • Original Paper
  • Experimental Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

A novel butyric acid derivative, pivaloyloxymethyl butyrate, AN-9, was previously shown to be a potent differentiating agent. AN-9 exerts a significant anticancer activity in vitro and in vivo. In all the activities examined, AN-9 was more potent than butyric acid. Here we show that AN-9 and butyric acid induce cell death by apoptosis. Exposure of HL-60 cells to butyric acid and AN-9 decreased cell numbers and induced cell differentiation and the appearance of typical apoptotic features. Induction of apoptosis and/or differentiation by AN-9 and butyric acid was dependent on the concentration and the time of exposure to the drugs. The advantage of AN-9 over butyric acid was further confirmed. Apoptosis induced by AN-9 occurred after a shorter exposure and at lower drug concentrations than that induced by butyric acid. Apoptosis by AN-9 was accompanied by reduction in Bcl-2 expression. Preincubation with antioxidants did not protect HL-60 cells from apoptosis induced by AN-9. HL-60 cells that were induced to differentiate by preincubation with retinoic acid or low AN-9 concentrations were more resistant to apoptosis, induced later by high concentrations of AN-9, than were undifferentiated cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AN-9:

pivaloyloxymethylbutyrate

References

  • Benito A, Grillot D, Nunez G, Fernandez-Luna JL (1995) Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 146:481–490

    Google Scholar 

  • Bundgaard H, Nielsen NM (1987) Esters ofN, N-disubstituted 2-hydroxyacetamides as novel highly biolabile prodrug type for carboxylic acid agents. J Med Chem 30:451–455

    Google Scholar 

  • Calabresse C, Venturini L, Ronco G, Villa P, Chomienne C, Belpomme D (1993) Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem Biophy Res Commun 195:31–38

    Google Scholar 

  • Calabresse C, Venturini L, Ronco G, Villa P, Degos L, Belpomme D, Chomienne C (1994) Selective induction of apoptosis in myeloid leukemic cell lines by monoacetone glucose-3 butyrate. Biochem Biophy Res Commun 201:266–283

    Google Scholar 

  • Delina D, Aiello A, Formelli F, Fontanella E, Costa A, Miyashita T, Reed JC, Pierotti MA (1995) Regulation of apoptosis induced by the retinoidN-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85:359–367

    Google Scholar 

  • Dive C, Hickman JA (1991) Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 64:192–196

    Google Scholar 

  • Filippovich I, Sorokina N, Khanna KK, Lavin MF (1994) Butyrate induced apoptosis in lymphoid cells preceded by transient overexpression of HSP70 mRNA. Biochem Biophys Res Commun 198:257–265

    Google Scholar 

  • Fischkoff SA, Hoessly MC, Rossi RM (1990) Characterization of sublines of HL-60 human leukemia cells resistant to induction of differentiation by butyric acid. Leukemia 4:302–306

    Google Scholar 

  • Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53:3186–3192

    Google Scholar 

  • Hague A, Manning AM, Hanlon KA, Huschtscha LI, Hart D, Paraskeva C (1993) Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 55:498–505

    Google Scholar 

  • Hare JD, Bahler DW (1986) Analysis of plasmodium falciparum growth in culture using acridine orange and flow cytometry. J Histochem Cytochem 34:215–220

    Google Scholar 

  • Hockenbery D, Nunez G, Milliman C, Schreber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336

    Google Scholar 

  • Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251

    Google Scholar 

  • Itoha N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243

    Google Scholar 

  • Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365–369

    Google Scholar 

  • Koeffler HP (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62:709–721

    Google Scholar 

  • Lotem J, Sachs L (1993) Regulation bybcl-2, c-myc, andp53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiative myeloid leukemic cells. Cell Growth Differ 4:41–47

    Google Scholar 

  • Martin SJ, Bradley JG, Cotter TG (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79:448–453

    Google Scholar 

  • Martin SJ, Lennon SV, Bonham AM, Cotter TG (1990) Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145:1859–1867

    Google Scholar 

  • McCarthy JV, Fernandes RS, Gotter TG (1994) Increased resistance to apoptosis associated with HL-60 myeloid differentiation status. Anticancer Res 14:2063–2072

    Google Scholar 

  • Miller AA, Kurschel E, Osieka R, Schmidt C (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23:1283–1287

    Google Scholar 

  • Miyashita and Reed (1993) Bcl-2 Oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell lne. Blood 81:151–157

    Google Scholar 

  • Naumovski L, Cleary ML (1994) Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83:2261–2267

    Google Scholar 

  • Nudelman A, Ruse M, Aviram A, Rabizadeh E, Shaklai M, Zimra Y, Rephaeli A (1992) Novel anticancer prodrugs of butyric acid. J Med Chem 35:687–694

    Google Scholar 

  • Park JR, Robertson K, Hickstein DD, Tsai S, Hockenbery DM, Collins SJ (1994) Dysregulatedbcl-2 expression inhibits apoptosis but not differentiation of retinoic acid induced HL-60 granulocytes. Blood 84:440–445

    Google Scholar 

  • Prasad KN (1980) Butyric acid: a small fatty acid with diverse biological functions. Life Sci. 27:1351–1358

    Google Scholar 

  • Prasad KN, Cohrs RJ, Sharma OK (1990) Decreased expression of c-mys and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture. Biochem Cell Biol 68:1250–1255

    Google Scholar 

  • Rabizadeh E, Shaklai M, Nudelman A, Eisenbach L, Rephaeli A (1993) Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. Febs Lett 328:225–229

    Google Scholar 

  • Ratan RR, Murphy TH, Baraban JM (1994) Oxidative stress induces apoptosis in embryonic cortical neurons. J Neurochem 62:376–379

    Google Scholar 

  • Rephaeli A, Rabizadeh E, Aviram A, Shaklai M, Ruse M, Nudelman A (1991) Derivatives of butyric acid as potential anti-neoplastic agents. Int J Cancer 49:66–72

    Google Scholar 

  • Rephaeli A, Nordenberg J, Aviram A, Rabizadeh E, Nudelman A, Novogrodsky A, Shaklai M (1994) Butyrate induced differentiation in leukemic myeloid cells; in vitro and in vivo studies. Int J Oncol: 4:1–5

    Google Scholar 

  • Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y (1995) Prevention of hypoxia induced cell death by Bcl-2 and Bcl-xl. Nature 374:811–813

    Google Scholar 

  • Solary E, Bertrand R, Kohn KW, Pommier Y (1993) Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81:1359–1368

    Google Scholar 

  • Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456–1462

    Google Scholar 

  • Toscani A, Sporano DR, Sporano KJ (1988) Molecular analysis of sodium butyrate induced growth arrest. Oncogene Res 3:223–238

    Google Scholar 

  • Vidali G, Boffa LC, Bradbury EM, Allfrey FG (1978) Butyrate suppression of histone deacetylation leads to accumulation of polyacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci USA 75:2239–2243

    Google Scholar 

  • Wolf D, Rotter V (1985) Major deletion in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82:790–794

    Google Scholar 

  • Xu HM, Tepper CG, Jones JB, Fernandez CE, Studzinski GP (1993) 1,25-Dihydroxyvitamin D3 protects HL-60 cells against apoptosis but down regulates the expression of thebcl-2 gene. Exp Cell Res 209:367–374

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work is part of the Ph.D. thesis of Yael Zimra of the Sackler School of Medicine, Tel Aviv University

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zimra, Y., Wasserman, L., Maron, L. et al. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. J Cancer Res Clin Oncol 123, 152–160 (1997). https://doi.org/10.1007/BF01214667

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01214667

Key words

Navigation